NewsRoom Articles - Page 58 of 218

WednesdayNov 22, 2023 1:57 pm

Amazon Gives Prime Members Round-the-Clock Virtual Healthcare Access at Reduced Cost

Amazon, which was founded in 1994, has grown from an online bookstore that competed with Barnes & Noble and local booksellers to a conglomerate involved a range of industries. The company recently recorded a new milestone, launching virtual healthcare through its One Medical service. This healthcare program can be accessed by members of Amazon Prime, either annually at $99 or monthly at $9. This is quite a steal, especially when compared to rates of nonmembers, which stand at $198 annually and $18 monthly. The One Medical service has different offerings, including its Treat Me Now feature, which offers guidance on…

WednesdayNov 22, 2023 9:45 am

Genprex Inc. (NASDAQ: GNPX) Granted Orphan Drug Designation in Small Cell Lung Cancer by FDA, Presented Data at Two October Events Focused on Lung Cancer

Genprex was granted orphan drug designation by the FDA earlier this year for development of REQORSA combined with Tecentriq in small cell lung cancer Use of REQORSA combined with Tecentriq is the subject of Genprex’s upcoming Acclaim-3 clinical trial Genprex took part in two events in October – the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics; and Genprex’s own hosted event, a Virtual Key Opinion Leaders on Bringing Gene Therapy to the Fight Against Lung Cancers Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients living with cancer and diabetes, was…

WednesdayNov 22, 2023 9:00 am

Clene Inc. (NASDAQ: CLNN) Capitalizing on the Promising Chemical and Therapeutic Properties of Nanocrystals to Address High Unmet Medical Needs

Clene is focused on developing and commercializing novel clean-surfaced nanotechnology (“CSN(R)”) therapeutics The company utilizes an electro-crystallization nanotherapeutics platform, which results in nanocrystals that exhibit catalytic activities multiple times higher than numerous other commercially available nanoparticles that the company has comparatively evaluated Clene is focusing on central nervous system (“CNS”) disorders like amyotrophic lateral sclerosis (“ALS”), multiple sclerosis (“MS”), and Parkinson’s disease (“PD”) Its lead investigational product, CNM-Au8(R), has so far demonstrated a good safety and tolerability profile, with Phase 2 trials suggesting efficacy in ALS patients Nanotechnology has attracted a great deal of the scientific community’s attention thanks to…

TuesdayNov 21, 2023 2:16 pm

Study Finds DNA Loops in Brain Tumors in Kids Amplify Relapse Risk

Medulloblastoma is a rare type of brain tumor that is primarily found in children. It is estimated that about 350 cases of this illness are diagnosed annually. This cancer often resists treatment, which involves a combination of radiation, surgery and chemotherapy. This, combined with the disease’s various subtypes, has made it harder for scientists to develop new therapies. Now, new research has discovered that medulloblastoma patients with tumors that contain circular extrachromosomal DNA have a heightened risk of relapse and mortality. For their research, the scientists compiled a database of patients with medulloblastoma using data from patients diagnosed at Rady’s…

TuesdayNov 21, 2023 9:45 am

Longeveron Inc. (NASDAQ: LGVN) Encouraged by Positive Results from Phase 2a Trial in Patients with Mild AD; Explores Paths Forward for the Development of Lomecel-B(TM)

Longeveron recently released topline results from its Phase 2a trial evaluating Lomecel-B(TM) as a potential treatment for mild AD The study met its primary safety endpoint across all four study groups and showed positive and statistically significant results in secondary endpoint involving the Composite Alzheimer’s Disease Score (“CADS”) for Lomecel-B(TM) and components of the CADS The positive results are expected to form the basis for further development of Lomecel-B(TM) as a potential treatment for mild AD Longeveron (NASDAQ: LGVN), a clinical-stage biotechnology company developing cellular therapies for aging-related and life-threatening conditions for which there is an unmet medical need, announced…

MondayNov 20, 2023 3:24 pm

Study Shows Patients Afflicted by Inflammatory Arthritis Face Numerous Mental Challenges at Work

A new study has found that individuals with inflammatory arthritis are plagued with psychological challenges that make it hard for them to maintain employment. The study, conducted by the Hospital for Special Surgery, was recently presented at the American College of Rheumatology Convergence 2023. One of the researchers involved in the study, Joan Westreich, stated that research had indicated that individuals suffering from inflammatory arthritis had a heightened risk for work disability, which could greatly impact their lives. Westreich also that within a decade of diagnosis, about 40% of those living with this condition wouldn’t be able to work. While…

FridayNov 17, 2023 11:25 am

Study Examines Role of African Sleeping Sickness in Body Wasting

African trypanosomiasis is a progressive illness that affects both humans and animals. The illness is caused by a parasite known as Trypanosoma brucei (T. brucei). In the course of infection, T. brucei colonizes adipose tissue and rapidly grows in the host. This, researchers theorize, may cause weight loss because it primarily affects the biggest visceral adipose tissue depot, the gonadal AT. The infection works by offsetting the balance between anabolism and catabolism, which takes place in the adipocytes’ lipid droplets. An increase in lipid catabolism then causes degradation of triacylglycerol, which is hydrolyzed by lipase, monoacylglycerol lipase and adipose triglyceride…

ThursdayNov 16, 2023 2:10 pm

Study Links Cat Parasite to Accelerated Frailty in Aging People

Toxoplasma gondii (T. gondii) is a single-cell parasite that can cause severe physical and mental conditions. This parasite is known to trigger risky behavior in hosts. The most common way for an individual to be exposed to this parasite is when disposing of cat litter. This is because while the parasite does affect rodents and birds, it thrives in cats. In felines, it can multiply in the cat’s intestines, with its eggs being excreted for easier and faster transmission. While the parasite can stay alive in the host for a long time, most healthy individuals rarely present with symptoms because…

ThursdayNov 16, 2023 9:45 am

Clene Inc. (NASDAQ: CLNN) Reports Q3 2023 Financial Results, Recent Operating Highlights for Its ALS Clinical Program

Clene recently released its financial results for the third quarter ended September 30, 2023, and provided recent operating highlights for its ALS clinical program The ALS clinical program includes two independent studies evaluating the safety and efficacy of the company’s lead investigational product CNM-Au8(R) The 24-month long-term data cut from the open-label extension of the RESCUE-ALS study showed a significant median survival benefit of 19.3 months, a significant 52% decreased risk of ALS clinical worsening events, and a 75% decreased risk of long-term all-cause mortality Clene also summarized long-term follow-up data from the HEALEY ALS platform trial, which demonstrated significantly…

WednesdayNov 15, 2023 1:48 pm

Blood Test Could Detect Worsening MS Symptoms in Patients

Multiple sclerosis is a chronic illness that affects an individual’s brain and spinal cord, resulting in problems moving one’s arms or legs, issues with vision, and problems with balance or sensation. While the cause of this disease is still not known, researchers theorize that it may be caused by the immune system of an individual attacking its own tissues. Estimates show that roughly 2.8 million individuals around the globe live with this illness. The disease’s symptoms often get worse as time goes by, which lowers the quality of life of some patients. Dr. Ari J. Green, cosenior author of a…

News and publishing service for medical and biotechnology related companies

Contact us: 512.354.7000

Amazon Gives Prime Members Round-the-Clock Virtual Healthcare Access at Reduced Cost

Genprex Inc. (NASDAQ: GNPX) Granted Orphan Drug Designation in Small Cell Lung Cancer by FDA, Presented Data at Two October Events Focused on Lung Cancer

Clene Inc. (NASDAQ: CLNN) Capitalizing on the Promising Chemical and Therapeutic Properties of Nanocrystals to Address High Unmet Medical Needs

Study Finds DNA Loops in Brain Tumors in Kids Amplify Relapse Risk

Longeveron Inc. (NASDAQ: LGVN) Encouraged by Positive Results from Phase 2a Trial in Patients with Mild AD; Explores Paths Forward for the Development of Lomecel-B(TM)

Study Shows Patients Afflicted by Inflammatory Arthritis Face Numerous Mental Challenges at Work

Study Examines Role of African Sleeping Sickness in Body Wasting

Study Links Cat Parasite to Accelerated Frailty in Aging People

Clene Inc. (NASDAQ: CLNN) Reports Q3 2023 Financial Results, Recent Operating Highlights for Its ALS Clinical Program

Blood Test Could Detect Worsening MS Symptoms in Patients

Official NewsWire Relationships

BioMedWire Currently Accepts

BioMedWire

Company Search

Site Search